Direct Flow Medical prosthesis is a nonmetallic, repositionable, recaptured valve (even after posts dilate), that does not require a pacemakers use during both implantation and post-dilatation.
The aim of this study was to evaluate new valve results to one year in patients with symptomatic severe aortic stenosis with 19 and 26 mm ring, EuroScore of at least 20 and comorbidities. 100 patients showed one-year survival of 90% and mild aortic regurgitation or even less were included.
J. Schofer
2014-05-23
Title: The DISCOVER trial: 1-year outcomes of a new-generation non metallic transcatheter aortic valve
